Obesity and sex influence insulin resistance and total and multimer adiponectin levels in adult neutered domestic shorthair client-owned cats

Domestic Animal Endocrinology

Volumn 47, Issue 1, 2014, Pages 55-64

  Bjornvad, C R ^a   Rand, J S ^b   Tan, H Y ^b   Jensen, K S ^a   Rose, F J ^b   Armstrong, P J ^c   Whitehead, J P ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Adipokine; Dual energy x ray absorptiometry; Feline; Gender

Indexed keywords

FELIDAE;

ADIPOCYTOKINE; ADIPONECTIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CAT; CAT DISEASE; CHEMISTRY; DUAL-ENERGY X-RAY ABSORPTIOMETRY; FELINE; FEMALE; GENDER; GENETICS; INSULIN RESISTANCE; MALE; METABOLISM; OBESITY; PHYSIOLOGY; SEX DIFFERENCE;

ADIPOKINE; DUAL-ENERGY X-RAY ABSORPTIOMETRY; FELINE; GENDER;

ADIPONECTIN; ANIMALS; CAT DISEASES; CATS; FEMALE; INSULIN RESISTANCE; MALE; OBESITY; SEX FACTORS;

EID: 84897670214     PISSN: 07397240     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.domaniend.2013.11.006     Document Type: Article

References (41)

1. Hoenig M. The cat as a model for human nutrition and disease. Curr Opin Clin Nutr Metab Care 2006, 9:584-588.
2. Radin M.J., Sharkey L.C., Holycross B.J. Adipokines: a review of biological and analytical principles and an update in dogs, cats, and horses. Vet Clin Pathol 2009, 38:136-156.
3. Rand J.S., Marshall R.D. Diabetes mellitus in cats. Vet Clin North Am Small Anim Pract 2005, 35:211-224.
4. Slingerland L.I., Fazilova V.V., Plantinga E.A., Kooistra H.S., Beynen A.C. Indoor confinement and physical inactivity rather than the proportion of dry food are risk factors in the development of feline type 2 diabetes mellitus. Vet J 2009, 179:247-253.
5. Reaven P. Metabolic syndrome. J Insur Med 2004, 36:132-142.
6. Henson M.S., O'Brien T.D. Feline models of type 2 diabetes mellitus. ILAR J 2006, 47:234-242.
7. Antuna-Puente B., Feve B., Fellahi S., Bastard J.P. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab 2008, 34:2-11.
8. Maachi M., Pieroni L., Bruckert E., Jardel C., Fellahi S., Hainque B., Capeau J., Bastard J.P. Systemic low-grade inflammation is related toboth circulating and adipose tissue TNFalpha, leptin and IL-6 levels in obese women. Int J Obes Relat Metab Disord 2004, 28:993-997.
9. Bastard J.P., Maachi M., Lagathu C., Kim M.J., Caron M., Vidal H., Capeau J., Feve B. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006, 17:4-12.
10. Appleton D.J., Rand J.S., Sunvold G.D. Plasma leptin concentrations are independently associated with insulin sensitivity in lean and overweight cats. J Feline Med Surg 2002, 4:83-93.
11. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006, 116:1784-1792.
12. Muranaka S., Mori N., Hatano Y., Saito T.R., Lee P., Kojima M., Kigure M., Yagishita M., Arai T. Obesity induced changes to plasma adiponectin concentration and cholesterol lipoprotein composition profile in cats. Res Vet Sci 2011, 91:358-361.
13. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257:79-83.
14. Hoenig M., Thomaseth K., Waldron M., Ferguson D.C. Insulin sensitivity, fat distribution, and adipocytokine response to different diets in lean and obese cats before and after weight loss. Am J Physiol Regul Integr Comp Physiol 2007, 292:227-234.
15. Spranger J., Kroke A., Mohlig M., Bergmann M.M., Ristow M., Boeing H., Pfeiffer A.F. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003, 361:226-228.
16. Lindsay R.S., Funahashi T., Hanson R.L., Matsuzawa Y., Tanaka S., Tataranni P.A., Knowler W.C., Krakoff J. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002, 360:57-58.
17. Hotta K., Funahashi T., Bodkin N.L., Ortmeyer H.K., Arita Y., Hansen B.C., Matsuzawa Y. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001, 50:1126-1133.
18. Basu R., Pajvani U.B., Rizza R.A., Scherer P.E. Selective downregulation of the high-molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects. Diabetes 2007, 56:2174-2177.
19. Garaulet M., Hernandez-Morante J.J., de Heredia F.P., Tebar F.J. Adiponectin, the controversial hormone. Public Health Nutr 2007, 10:1145-1150.
20. Kaser S., Tatarczyk T., Stadlmayr A., Ciardi C., Ress C., Tschoner A., Sandhofer A., Paulweber B., Ebenbichler C.F., Patsch J.R. Effect of obesity and insulin sensitivity on adiponectin isoform distribution. Eur J Clin Invest 2008, 38:827-834.
21. Hara K., Horikoshi M., Yamauchi T., Yago H., Miyazaki O., Ebinuma H., Imai Y., Nagai R., Kadowaki T. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006, 29:1357-1362.
22. Verkest K.R., Fleeman L.M., Rand J.S., Morton J.M. Evaluation of beta-cell sensitivity to glucose and first-phase insulin secretion in obese dogs. Am J Vet Res 2011, 72:357-366.
23. Verkest K.R., Rand J.S., Fleeman L.M., Morton J.M., Richards A.A., Rose F.J., Whitehead J.P. Distinct adiponectin profiles might contribute to differences in susceptibility to type 2 diabetes in dogs and humans. Domest Anim Endocrinol 2011, 41:67-73.
24. Tvarijonaviciute A., Ceron J.J., Holden S.L., Morris P.J., Biourge V., German A.J. Effects of weight loss in obese cats on biochemical analytes related to inflammation and glucose homeostasis. Domest Anim Endocrinol 2012, 42:129-141.
25. Ishioka K., Omachi A., Sasaki N., Kimura K., Saito M. Feline adiponectin: molecular structures and plasma concentrations in obese cats. J Vet Med Sci 2009, 71:189-194.
26. Tan H.Y., Rand J.S., Morton J.M., Fleeman L.M., Jane A.P., Coradini M., Ishioka K., Verkest K.R., Richards A.A., Rawlings J.M., Rose F.J., Whitehead J.P. Adiponectin profiles are affected by chronic and acute changes in carbohydrate intake in healthy cats. Gen Comp Endocrinol 2011, 172:468-474.
27. LaFlamme D.P. Development and validation of a body condition score system for cats: a clinical tool. Feline Pract 1997, 25:13-18.
28. Bjornvad C.R., Nielsen D.H., Armstrong P.J., McEvoy F., Hoelmkjaer K.M., Jensen K.S., Pedersen G.F., Kristensen A.T. Evaluation of a nine-point body condition scoring system in physically inactive pet cats. Am J Vet Res 2011, 72:433-437.
29. Slingerland L.I., Robben J.H., van Haeften T.W., Kooistra H.S., Rijnberk A. Insulin sensitivity and beta-cell function in healthy cats: assessment with the use of the hyperglycemic glucose clamp. Horm Metab Res 2007, 39:341-346.
30. Hoenig M., Thomaseth K., Brandao J., Waldron M., Ferguson D.C. Assessment and mathematical modeling of glucose turnover and insulin sensitivity in lean and obese cats. Domest Anim Endocrinol 2006, 31:373-389.
31. Appleton D.J., Rand J.S., Sunvold G.D. Basal plasma insulin and homeostasis model assessment (HOMA) are indicators of insulin sensitivity in cats. J Feline Med Surg 2005, 7:183-193.
32. Backus R.C., Havel P.J., Gingerich R.L., Rogers Q.R. Relationship between serum leptin immunoreactivity and body fat mass as estimated by use of a novel gas-phase Fourier transform infrared spectroscopy deuterium dilution method in cats. Am J Vet Res 2000, 61:796-801.
33. Tvarijonaviciute A., German A.J., Martinez-Subiela S., Tecles F., Ceron J.J. Analytical performance of commercially-available assays for feline insulin-like growth factor 1 (IGF-1), adiponectin and ghrelin measurements. J Feline Med Surg 2012, 14:138-146.
34. Bjornvad C.R., Wiinberg B., Kristensen A.T. Obesity increases initial rate of fibrin formation during blood coagulation in domestic shorthaired cats. J Anim Physiol Anim Nutr (Berl) 2012, 96:834-841.
35. Mazaki-Tovi M., Abood S.K., Schenck P.A. Effect of omega-3 fatty acids on serum concentrations of adipokines in healthy cats. Am J Vet Res 2011, 72:1259-1265.
36. Appleton D.J., Rand J.S., Sunvold G.D. Insulin sensitivity decreases with obesity, and lean cats with low insulin sensitivity are at greatest risk of glucose intolerance with weight gain. J Feline Med Surg 2001, 3:211-228.
37. Lederer R., Rand J.S., Jonsson N.N., Hughes I.P., Morton J.M. Frequency of feline diabetes mellitus and breed predisposition in domestic cats in Australia. Vet J 2009, 179:254-258.
38. Reeve-Johnson M.K., Rand J.S., Anderson S., Appleton D.J., Vankan D., Morton J.M. Dosing obese cats on a per Kg basis artificially affects some measures of glucose tolerance in a glucose tolerance test. J Vet Intern Med 2013, 27:691. (abstract).
39. Hoenig M., Alexander S., Holson J., Ferguson D.C. Influence of glucose dosage on interpretation of intravenous glucose tolerance tests in lean and obese cats. J Vet Intern Med 2002, 16:529-532.
40. Silha J.V., Krsek M., Skrha J.V., Sucharda P., Nyomba B.L., Murphy L.J. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 2003, 149:331-335.
41. Hung J., McQuillan B.M., Thompson P.L., Beilby J.P. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. Int J Obes 2008, 32:772-779.